Cargando…
Chronic Activation of LXRα Sensitizes Mice to Hepatocellular Carcinoma
The oxysterol receptor liver X receptor (LXR) is a nuclear receptor best known for its function in the regulation of lipid and cholesterol metabolism. LXRs, both the α and β isoforms, have been suggested as potential therapeutic targets for several cancer types. However, there was a lack of report o...
Autores principales: | Xie, Yang, Sun, Runzi, Gao, Li, Guan, Jibin, Wang, Jingyuan, Bell, Aaron, Zhu, Junjie, Zhang, Min, Xu, Meishu, Lu, Peipei, Cai, Xinran, Ren, Songrong, Xu, Pengfei, Monga, Satdarshan P., Ma, Xiaochao, Yang, Da, Liu, Yulan, Lu, Binfeng, Xie, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035576/ https://www.ncbi.nlm.nih.gov/pubmed/34981658 http://dx.doi.org/10.1002/hep4.1880 |
Ejemplares similares
-
Activation of Liver X Receptor α Sensitizes Mice to T‐Cell Mediated Hepatitis
por: Gao, Li, et al.
Publicado: (2020) -
Hepatocyte estrogen sulfotransferase inhibition protects female mice from concanavalin A–induced T cell–mediated hepatitis independent of estrogens
por: Wang, Jingyuan, et al.
Publicado: (2023) -
Loss of TAZ after YAP deletion severely impairs foregut development and worsens cholestatic hepatocellular injury
por: Gabdulkhakova, Adelya, et al.
Publicado: (2023) -
BCL9/BCL9L in hepatocellular carcinoma: Will it or Wnt it be the next therapeutic target?
por: Moghe, Akshata, et al.
Publicado: (2020) -
The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1
por: Xi, Yue, et al.
Publicado: (2021)